rare diseases

PRINCETON, N.J., June 30, 2026 Kyowa Kirin has announced new clinical analyses demonstrating that mogamulizumab continues to deliver meaningful...

CARY, N.C., June 30, 2026 Allucent, a global specialty Contract Research Organization (CRO) serving small and mid-sized biopharmaceutical companies,...

STOCKHOLM, Sweden, June 26, 2026 Sobi announced that it has received a Complete Response Letter (CRL) from the U.S....

TOKYO, Japan and FRANKFURT, Germany, June 19, 2026 Teijin Pharma Limited and Merz Therapeutics GmbH have announced that Japan’s...

SAN DIEGO, June 19, 2026 Fapon Biopharma and MOTE Therapeutics have announced plans to present their innovative dual-targeting, dual-platform...

BOSTON and ROLLE, Switzerland, June 19, 2026 SOPHiA GENETICS, a global leader in AI-driven precision medicine, has announced the...

NAIROBI, Kenya / KAMPALA, Uganda, June 19, 2026 African health leaders, government officials, clinicians, patient advocates, and international partners...

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 15, 2026 Takeda has unveiled new pivotal Phase 3 data demonstrating that oveporexton...

CAMBRIDGE, Mass., June 13, 2026 Agios Pharmaceuticals, Inc. announced detailed results from the 52-week double-blind portion of the global...

HYOGO, Japan, June 8, 2026 JCR Pharmaceuticals Co., Ltd. announced new clinical findings from its J-Brain Cargo® blood-brain barrier...